Cancer clinical trials in the region Nouvelle-Aquitaine
254 currently recruiting clinical trials
Looking for clinical trials?
Clinical trial search is a complex process, with countless criteria to consider. Our AI assistant navigates this complexity with precise, expert-level analysis of the most relevant trials based on your medical profile. Our database is fully up to date, so you see only actively recruiting sites. It's fast and easy:
- Create your account
- Copy-paste your latest medical report
- Our AI-based assistant does the rest for you
Whether you are a patient or a doctor, create an account to find and apply for the most relevant clinical trials:
Phase 2
Colon cancer
Rectal cancer
Anal cancer
#NCT04268121
#2024-515603-19-01
Neuroendocrine tumor
Localized
None
Systemic Treatment-Naive
CHU - Haut-Lévêque - Bordeaux (Pessac), Centre Hospitalier Universitaire de Poitiers - Site de la Milétrie (Poitiers)
GERCOR - Groupe Coopératif Multidisciplinaire d'Oncologie
Phase 2
Lymphoma
#NCT06271057
#2023-506705-20-00
B cell lymphoma
Large B cell lymphoma
Primary mediastinal lymphoma
Indolent transformed lymphoma
> 60 ml/min
2
3 or more
Systemic Treatment-Naive
CHU - Haut-Lévêque - Bordeaux (Pessac)
The Lymphoma Academic Research Organisation (LYSARC)
Phase 2
Breast cancer
#NCT06247995
#2023-506717-21-00
HER2 Negative
HR Positive
Metastatic
1
2
3 or more
Targeted therapy
Hormone therapy
Chemotherapy
Institut Bergonié (Bordeaux)
Novartis
Phase 2
Lung cancer
#NCT06219317
#2023-508741-40-00
NSCLC (Non-Small Cell Lung Cancer)
Metastatic
None
Systemic Treatment-Naive
ALK
EGFR
ROS-1
Surgery
Radiotherapy
Centre Hospitalier de la Côte Basque (Bayonne)
EORTC - Organisation Européenne pour la Recherche et le Traitement du Cancer
Phase 2
Prostate cancer
#NCT05346848
#2023-509494-23-00
Localized
None
Systemic Treatment-Naive
Surgery
Chemotherapy
Radiotherapy
Hormone therapy
Internal Vectorised Radiotherapy (IVR)
Institut Bergonié (Bordeaux)
Institut Bergonié
Phase 2
Lung cancer
#NCT06161441
#2023-505172-29-00
NSCLC (Non-Small Cell Lung Cancer)
Localized
None
Systemic Treatment-Naive
ALK
EGFR
Immunotherapy
Chemotherapy
Radiotherapy
Centre Hospitalier Universitaire Dupuytren (Limoges), Centre Hospitalier Universitaire de Bordeaux (Bordeaux)
Regeneron Pharmaceuticals
Phase 2
Lung cancer
#NCT06172478
#2023-507641-29-00
NSCLC (Non-Small Cell Lung Cancer)
Non-squamous NSCLC
Locally Advanced
Metastatic
1
2
Immunotherapy
Chemotherapy
ALK
BRAF
EGFR
HER2
KRAS G12C
MET
NTRK-1/2/3
RET
ROS-1
Systemic Treatment-Naive
Groupe Hospitalier Saint André (Bordeaux)
Daiichi Sankyo
Phase 2
Stomach and esophageal cancer
#NCT06253611
#2023-506753-38-00
Stomach
Oesogastric junction
Esophagus
Adenocarcinoma
Locally Advanced
Metastatic
None
Systemic Treatment-Naive
HER2
Immunotherapy
Centre Hospitalier Universitaire de Poitiers - Site de la Milétrie (Poitiers)
GERCOR - Groupe Coopératif Multidisciplinaire d'Oncologie
Phase 2
Prostate cancer
#NCT06172478
#2023-507641-29-00
Adenocarcinoma
Metastatic Castration-resistant
1
2
3 or more
Chemotherapy
Hormone therapy
Systemic Treatment-Naive
Groupe Hospitalier Saint André (Bordeaux)
Daiichi Sankyo
Phase 2
Liver and bile duct cancer
#NCT05265208
#2024-516683-29-00
Intrahepatic cholangiocarcinoma
Localized
None
Systemic Treatment-Naive
Chemotherapy
Radiotherapy
CHU - Haut-Lévêque - Bordeaux (Pessac)
Centre Eugène Marquis